In the United States, specialty drugs make up more than half of all prescription drug spending. These medicines are often expensive and need complicated approval steps before patients can get them. About 75% of drugs being developed are specialty treatments. Even though they are important, many clinics and healthcare systems find it hard to handle the paperwork and processes needed for specialty drugs. Tasks like checking insurance benefits, getting prior authorizations, and billing are done by hand. This can cause mistakes and take a lot of time. Because of this, patients may wait weeks or even months to start their treatments.
These long waits not only affect how well patients do but also cause financial problems for clinics. Staff members must spend a lot of time on approvals instead of focusing on patient care. As the number of specialty drug prescriptions grows, these problems get worse.
One way to fix these issues is through autonomous AI agents. These are computer programs that act like virtual workers and handle healthcare tasks with little need for human help. Mandolin is one company using this technology. Its AI system works like a full-time employee by managing benefits checks, prior authorizations, and billing on its own, 24 hours a day. This helps reduce the workload for staff.
Mandolin’s AI is now used in over 700 clinics across the country. These clinics include large infusion centers, specialty pharmacies, and health systems that serve more than 250,000 new patients each year. Because of the AI, work that took days can now be done in just hours. Clinics say patients can start their specialty drug treatments weeks earlier than before. Providers also report earning more money because approvals happen faster and staff spend less time doing manual tasks.
The founders of Mandolin, Will Yin and Rohit Rustagi, used to work in medicine. They saw that science alone was not enough without making healthcare processes simpler. Their own experiences with family members who had trouble getting specialty drugs inspired them to build AI tools to handle these problems better.
Healthcare today needs clinical and administrative teams to work well together. AI tools like Mandolin’s autonomous agents help with this by connecting to different healthcare systems and managing tasks without human help. This leads to better accuracy and the ability to handle more work.
These AI agents automate tasks such as:
By automating these steps, AI reduces repetitive tasks for staff. This lets healthcare workers focus more on patient care. It also makes healthcare operations more consistent.
Mandolin’s system uses many AI agents that work together like a team. Each AI “teammate” has a specific role but they communicate and handle the whole workflow from start to finish. Unlike old software that needs a lot of human input, these agents work on their own. They solve problems, adjust to different insurance plans, and handle unusual cases.
This is important because U.S. insurance rules, drug lists, and electronic health records vary a lot. The AI can work all day and night, stopping tasks from piling up outside office hours. This speeds up approvals and lets patients get care faster.
AI agents help more than just fast patient access. Clinics and health systems see benefits like:
For clinic owners and managers, these improvements make the office run smoother, help use resources better, and let them care for more patients.
AI is also advancing in other areas of healthcare besides specialty drug workflows. Some partnerships, like NVIDIA working with IQVIA, Illumina, Mayo Clinic, and the Arc Institute, use AI to speed up drug research and clinical trials.
For example, IQVIA uses NVIDIA’s AI tools to build models with huge amounts of real healthcare data. They automate paperwork in clinical trials, making patient recruitment faster while following regulations. Illumina uses AI to improve studying genes and finding drug targets. Mayo Clinic applies AI to analyze millions of tissue images for better diagnoses. Arc Institute develops AI that links DNA, RNA, and proteins to help with drug development.
Though these projects focus on research, their automation also supports clinical workflows similar to Mandolin’s AI. This shows how automation is becoming a bigger part of healthcare—from research to patient care administration.
Healthcare in the U.S. is becoming more complex, especially with specialty drugs that need lots of rules and documents. Clinics that help patients get these drugs often face long delays because of this complicated process.
Using AI automation can reduce the work burden on staff and speed up patient care. This means:
Because healthcare is competitive and specialty drug use keeps growing, clinics that adopt AI tools will likely work better and help patients more.
Specialty drug access in U.S. healthcare is becoming harder to manage for clinic administrators and IT staff. Autonomous AI agents like those from Mandolin offer a way to automate important tasks such as benefits checks, prior authorizations, and billing. These agents work fast, accurately, and can handle large workloads.
More than 700 clinics now use these AI agents, serving over 250,000 new patients every year. This reduces the time spent on paperwork, helps patients get needed therapies faster, and increases clinic revenue. These factors are key for providers working in today’s complex healthcare system.
As AI and automation keep growing, healthcare facilities that use these tools will likely see better operations and more benefits for staff and patients alike.
Mandolin’s AI agents aim to close the time-to-access for specialty therapies treating conditions like cancer and Alzheimer’s by automating and speeding up approval workflows, thus helping patients get access to expensive and complex specialty pharmaceuticals faster.
They act as full-time employee equivalents by reading, reasoning, and completing tasks such as benefits verification, prior authorization, and billing across multiple systems, working 24/7 to efficiently handle administrative workflows.
Specialty drugs are costly, take weeks or months for approval, involve complex workflows, and constitute over half of U.S. prescription spend and 75% of the FDA drug pipeline, overwhelming existing healthcare systems.
Healthcare providers report reducing administrative tasks from days to hours, increasing revenue, lowering manual labor overhead, and getting patients on therapy weeks earlier than traditional processes.
Will Yin and Rohit Rustagi, both with medical backgrounds and personal experiences with family members struggling with specialty drug access, founded Mandolin to solve systemic bottlenecks in healthcare delivery.
Unlike traditional tools, Mandolin’s AI agents operate autonomously as a scalable, 24/7 virtual workforce with higher accuracy, performing multi-step, complex workflows end-to-end rather than just supporting human tasks.
Mandolin’s AI agents are live at over 700 clinics nationwide, serving more than 250,000 new patients annually, including large infusion providers and specialty pharmacies.
Multi-agent AI enables automation of complex, multi-step healthcare workflows end-to-end, allowing Mandolin’s agents to collaborate and execute tasks comprehensively without manual intervention.
By automating administrative steps traditionally done manually, Mandolin accelerates access to specialty therapies, enabling patients to start treatments weeks earlier than before.
They recognized that scientific advances were not enough without system-level improvements; the real bottleneck was inefficient processes, which AI technology like Mandolin’s platform could effectively address.